Skip to content
10-Q

Quarterly Report

BIOTRICITY INC. BTCY

0001493152-24-033159

← back to feed
Filed
Aug 19, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Aug 19, 2024 22.45M sh
Cash And Equivalents Q1 2025 · Jun 30, 2024 $100.73K
Cash And Equivalents Q1 2025 · Mar 31, 2024 $786.06K
Current Liabilities Q1 2025 · Jun 30, 2024 $20.58M
Current Liabilities Q1 2025 · Mar 31, 2024 $22.7M
Total Liabilities Q1 2025 · Jun 30, 2024 $33.01M
Total Liabilities Q1 2025 · Mar 31, 2024 $35.92M
Current Assets Q1 2025 · Jun 30, 2024 $4.09M
Current Assets Q1 2025 · Mar 31, 2024 $4.47M
Total Assets Q1 2025 · Jun 30, 2024 $5.42M
Total Assets Q1 2025 · Mar 31, 2024 $5.94M
Shares Diluted restated Q1 2025 · Jun 30, 2023 8.75M sh
Operating Cash Flow Q1 2025 · Jun 30, 2023 −$1.83M
Stockholders Equity Q1 2025 · Jun 30, 2023 −$23.41M
Stockholders Equity Q1 2025 · Mar 31, 2023 −$19.85M
Eps Diluted restated Q1 2025 · Jun 30, 2023 −$0.41
Eps Basic restated Q1 2025 · Jun 30, 2023 −$0.41
Sga Expense Q1 2025 · Jun 30, 2023 $3.52M
Rd Expense Q1 2025 · Jun 30, 2023 $712.98K
Net Income Q1 2025 · Jun 30, 2023 −$3.41M
Operating Income Q1 2025 · Jun 30, 2023 −$2.32M
Gross Profit Q1 2025 · Jun 30, 2023 $1.92M
Cost Of Revenue Q1 2025 · Jun 30, 2023 $1.1M
Revenue Q1 2025 · Jun 30, 2023 $3.02M